Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer

Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer and carries the worst prognosis, characterized by the lack of progesterone, estrogen, and HER2 gene expression. This study aimed to analyze cancer stemness-related gene signature to determine patients’ risk stratifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gul, Samina, Pang, Jianyu, Yuan, Hongjun, Chen, Yongzhi, yu, Qian, Wang, Hui, Tang, Wenru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662149/
https://www.ncbi.nlm.nih.gov/pubmed/37985782
http://dx.doi.org/10.1038/s41597-023-02709-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662149/
https://www.ncbi.nlm.nih.gov/pubmed/37985782
http://dx.doi.org/10.1038/s41597-023-02709-8

Ejemplares similares